Fund+ — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
Co-investorsBioMedPartnersHadean VenturescoparionInkefLSP (Life Sciences Partners)Sunstone Capital
Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.
BiotechDeep TechHealthtechMedical DevicesLouvain, BE
Dr. Denis Dufrane(Founder & Professor)in
BoardEric Paul Pâques(Chairman)
Co-investorsNew Science VenturesVIVES Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.